These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33993846)

  • 1. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
    Liang L; Kang H; Jia J
    Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 5. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p.
    Wang X; Zhang Y; Li W; Liu X
    J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
    Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
    Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis.
    Jin W; Zhang H; Li M; Lin S
    Cancer Biother Radiopharm; 2023 Mar; 38(2):122-131. PubMed ID: 32614615
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
    Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
    Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis.
    Zhang Z; Wang H
    Cancer Manag Res; 2021; 13():787-794. PubMed ID: 33536786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
    Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
    BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S; Han B; Li Z; Sun D
    Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization.
    Xia Y; Lv J; Jiang T; Li B; Li Y; He Z; Xuan Z; Sun G; Wang S; Li Z; Wang W; Wang L; Xu Z
    J Exp Clin Cancer Res; 2021 Mar; 40(1):103. PubMed ID: 33731207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
    Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
    Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
    Lei Y; Tang L; Hu J; Wang S; Liu Y; Yang M; Zhang J; Tang B
    Biomed Pharmacother; 2020 May; 125():109896. PubMed ID: 32007918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.